Perspective Therapeutics (CATX) Revenue (2010 - 2023)

Perspective Therapeutics (CATX) has 14 years of Revenue data on file, last reported at -$4.9 million in Q4 2023.

• For the quarter ending Q4 2023, Revenue changed N/A year-over-year to -$4.9 million; the trailing twelve-month figure through Dec 2023 stood at $846000.0 (changed N/A YoY), and the FY2023 full-year result was $1.4 million, changed N/A from the prior year.
• Revenue declined to -$4.9 million in Q4 2023, from $2.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $7.1 million in Q3 2022 to a low of -$4.9 million in Q4 2023.
• A 5-year average of $2.4 million and a median of $2.4 million in 2020 frame the typical range for Revenue.
• Across the five-year window, Revenue surged 178.16% in 2022 and slumped 72.3% in 2023, its largest moves.
• Tracing CATX's Revenue over 5 years: stood at $2.2 million in 2019, then gained by 6.94% to $2.4 million in 2020, then grew by 19.37% to $2.8 million in 2021, then surged by 153.27% to $7.1 million in 2022, then slumped by 168.73% to -$4.9 million in 2023.
• Business Quant data shows CATX's Revenue at -$4.9 million in Q4 2023, $2.2 million in Q3 2023, and $1.5 million in Q2 2023.